On Wednesday, November 23, the United States Trade Representative (USTR) announced in a Federal Register notice that Section 301 tariff exclusions for 81 COVID-related medical care products would be extended an additional 90 days. The exclusions were previously scheduled to expire on November 30, 2022, but will now be extended through February 28, 2023. The USTR may consider further extensions or modifications in the future as appropriate.